Delaying Renal Transplant after Radical Prostatectomy for Low-Risk Prostate Cancer

• Published in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation Vol. 13 Suppl 3; p. 74
• Main Authors: Özçelik, Ümit, Bircan, Hüseyin Yüce, Karakayalı, Feza, Moray, Gökhan, Demirağ, Alp
• Format: Journal Article
• Language: English
• Published: Turkey 01-11-2015
• Subjects: Adenocarcinoma - blood; Adenocarcinoma - pathology; Adenocarcinoma - surgery; Biopsy; Humans; Immunosuppressive Agents - therapeutic use; Kallikreins - blood; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - diagnosis; Kidney Failure, Chronic - surgery; Kidney Transplantation; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Patient Selection; Prostate-Specific Antigen - blood; Prostatectomy; Prostatic Neoplasms - blood; Prostatic Neoplasms - complications; Prostatic Neoplasms - pathology; Prostatic Neoplasms - surgery; Risk Assessment; Risk Factors; Time Factors; Time-to-Treatment; Treatment Outcome
• ISSN: 2146-8427
• DOI: 10.6002/ect.tdtd2015.P28

To minimize the recurrence of a previously treated neoplasm in organ recipients, a period of 2 to 5 years without recurrence is advocated for most malignancies. However, prostate cancer is different because of its biological properties, diagnosis, and treatment. Most prostate cancers are detected at a low stage and demonstrate slow growth after detection. Definitive treatment with radical prostatectomy affords excellent results. Renal transplant candidates with early-stage prostate cancer have a higher risk of dying on dialysis than dying from prostate cancer; therefore, renal transplant candidates with organ-confined prostate cancer should be immediately considered for transplant.